These results suggest that bladder cancer progression from Ta to T1+ stage tumors involves the increased expression of genes in mitogenic, cancer-associated pathways related to FGFR3 and ErbB family signaling. This evidence concerns the gene FGFR3 and urinary bladder cancer.